Stryker continues to deliver strong organic growth, having posted organic growth rates of around 10% for a long period of time now. Learn more about SYK stock here.

Stryker Corp (SYK) reports robust sales and EPS growth, raises full-year outlook despite facing tariff and supply chain ...

The medical device maker posted revenue of $6.06 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $6.04 billion. Stryker expects full-year earnings in ...

Stryker's Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite an upbeat 2025 outlook.

Stryker Corp (($SYK)) has held its Q3 earnings call. Read on for the main highlights of the call. Stryker Corp’s recent earnings call painted a ...

Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter Results Reported net sales increased 10.3% to $6.1 ...

Stryker Corp ( ($SYK) ) has released its Q3 earnings. Here is a breakdown of the information Stryker Corp presented to its investors. Stryker ...

Western movie icon John Wayne lost the Academy Award for 'Best Actor' and said that the film he lost to "threw acid on the ...

Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year ...

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and ...

Shares of medical technology company Stryker (NYSE:SYK) fell 2.9% in the afternoon session after it reported underwhelming ...

Analysts have recently evaluated Stryker and provided 12-month price targets. The average target is $417.57, accompanied by a ...